AI in Life Sciences

Implement AI faster without losing compliance

AI is accelerating digital transformation in life sciences. But implementing AI within a GxP-regulated environment introduces specific risks, especially when data is spread across multiple systems and processes.

Without the right foundations, organizations face challenges like inconsistent data, missing audit trails, and traceability gaps. At the same time, model transparency and explainability are increasingly scrutinized during audits. And because AI models evolve over time, a robust lifecycle management approach, aligned with CSA principles, becomes essential.

In this interactive webinar, QbD Group and delaware share how their combined expertise enables a pragmatic, integrated, and validated approach to implementing AI in regulated life sciences environments, so you can move from proof-of-concept to compliant deployment with confidence.

QbD Group supports life sciences companies worldwide in achieving the highest quality and safety standards, from idea to patient, with expertise in quality assurance, regulatory compliance, clinical services, and digital solutions.

delaware is a global consultancy and SAP Platinum Partner, guiding organizations through their business and digital transformations with end-to-end IT and enterprise technology solutions.

Together, we help life sciences companies bridge the gap between technology and compliance — ensuring every digital initiative is validated, inspection-ready, and future-proof from day one.

Our expertise in software implementation, validation, and IT partnerships bridges the gap between regulatory requirements, business processes, and technology. Whether you want to modernize workflows, enhance data utilization, or future-proof your systems, we guide you every step of the way.

Our digitalization solutions